Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Puma Biotechnology ROA 2010-2025 | PBYI

Current and historical return on assets (ROA) values for Puma Biotechnology (PBYI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Puma Biotechnology ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $0.04B $0.20B 17.72%
2024-12-31 $0.03B $0.21B 13.60%
2024-09-30 $0.02B $0.22B 10.10%
2024-06-30 $0.01B $0.21B 3.75%
2024-03-31 $0.02B $0.21B 7.07%
2023-12-31 $0.02B $0.23B 10.11%
2023-09-30 $0.00B $0.20B 1.46%
2023-06-30 $0.00B $0.20B -1.47%
2023-03-31 $0.00B $0.20B 1.97%
2022-12-31 $0.00B $0.22B 0.00%
2022-09-30 $0.01B $0.20B 4.87%
2022-06-30 $-0.04B $0.19B -16.51%
2022-03-31 $-0.05B $0.20B -21.44%
2021-12-31 $-0.03B $0.23B -11.93%
2021-09-30 $-0.05B $0.23B -19.41%
2021-06-30 $-0.03B $0.26B -13.27%
2021-03-31 $-0.03B $0.26B -10.11%
2020-12-31 $-0.06B $0.24B -24.10%
2020-09-30 $-0.06B $0.26B -22.70%
2020-06-30 $-0.04B $0.26B -17.55%
2020-03-31 $-0.08B $0.23B -35.16%
2019-12-31 $-0.08B $0.24B -28.90%
2019-09-30 $-0.10B $0.23B -35.78%
2019-06-30 $-0.09B $0.24B -34.68%
2019-03-31 $-0.10B $0.33B -37.75%
2018-12-31 $-0.11B $0.26B -50.90%
2018-09-30 $-0.15B $0.23B -73.46%
2018-06-30 $-0.21B $0.23B -112.06%
2018-03-31 $-0.24B $0.17B -140.67%
2017-12-31 $-0.29B $0.17B -158.27%
2017-09-30 $-0.30B $0.18B -145.94%
2017-06-30 $-0.29B $0.17B -149.29%
2017-03-31 $-0.28B $0.22B -144.00%
2016-12-31 $-0.28B $0.25B -145.22%
2016-09-30 $-0.27B $0.13B -141.87%
2016-06-30 $-0.26B $0.17B -117.12%
2016-03-31 $-0.26B $0.21B -101.28%
2015-12-31 $-0.24B $0.24B -83.42%
2015-09-30 $-0.22B $0.27B -83.82%
2015-06-30 $-0.20B $0.30B -82.56%
2015-03-31 $-0.17B $0.33B -80.65%
2014-12-31 $-0.14B $0.16B -75.63%
2014-09-30 $-0.11B $0.17B -64.16%
2014-06-30 $-0.09B $0.20B -56.06%
2014-03-31 $-0.06B $0.22B -44.44%
2013-12-31 $-0.06B $0.10B -45.08%
2013-09-30 $-0.06B $0.12B -45.52%
2013-06-30 $-0.07B $0.13B -63.89%
2013-03-31 $-0.08B $0.14B -80.43%
2012-12-31 $-0.08B $0.15B -105.26%
2012-09-30 $-0.06B $0.04B -134.04%
2012-06-30 $-0.04B $0.04B -97.37%
2012-03-31 $-0.02B $0.05B -81.48%
2011-12-31 $-0.01B $0.06B -72.73%
2011-09-30 $0.00B $0.00B 0.00%
2011-06-30 $0.00B $0.00B 0.00%
2011-03-31 $0.00B $0.00B 0.00%
2010-12-31 $0.00B $0.00B 0.00%
2010-09-30 $0.00B $0.00B 0.00%
2010-06-30 $0.00B $0.00B 0.00%
2010-03-31 $0.00B $0.00B 0.00%
2009-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.159B $0.231B
Puma Biotechnology, Inc. is a small cancer biotech whose only marketed product, Nerlynx (neratinib) was launched in the United Statesfor the treatment of early stage HER2-positive breast cancer in patients who have been previously treated with Roche's Herceptin-based adjuvant therapy. The drug was also approved in the European Union. Nerlynx in combination with Roche's Xeloda was approved?by the Food and Drug Administration for third-line HER2-positive metastatic breast cancer. Meanwhile, several additional studies on Nerlynx targeting different types of breast cancer patient populations as well as other types of cancers are currently underway. A key analysis of Nerlynx is the phase II SUMMIT basket study for treating solid tumors in patients with activating EGFR, HER2 or HER4 mutated cancers. Puma markets Nerlynx in the United States and has several sub-licenses in various regions outside the United States to commercialize Nerlynx in some international markets.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $216.937B 16.19
Amgen (AMGN) United States $155.574B 13.94
Gilead Sciences (GILD) United States $134.966B 14.02
Vertex Pharmaceuticals (VRTX) United States $113.214B 0.00
Bristol Myers Squibb (BMY) United States $95.364B 6.38
GSK (GSK) United Kingdom $77.943B 9.33
CSL (CSLLY) Australia $75.392B 0.00
Regeneron Pharmaceuticals (REGN) United States $55.032B 13.36
Alnylam Pharmaceuticals (ALNY) United States $40.381B 0.00
Argenex SE (ARGX) Netherlands $33.104B 90.36
BioNTech SE (BNTX) Germany $25.609B 0.00
Royalty Pharma (RPRX) United States $19.600B 8.28
Insmed (INSM) United States $19.480B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $18.796B 0.00
Biogen (BIIB) United States $18.615B 8.03
Illumina (ILMN) United States $14.325B 27.17
Genmab (GNMSF) Denmark $13.948B 14.26
Genmab (GMAB) Denmark $13.568B 15.22
Incyte (INCY) United States $13.252B 100.68
Exelixis (EXEL) United States $11.009B 18.69
Ascendis Pharma (ASND) Denmark $10.814B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.548B 17.13
QIAGEN (QGEN) Netherlands $10.394B 20.22
Moderna (MRNA) United States $10.017B 0.00
Exact Sciences (EXAS) United States $10.002B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $9.633B 24.60
Blueprint Medicines (BPMC) United States $8.279B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.030B 0.00
Bio-Techne Corp (TECH) United States $7.821B 29.18
Roivant Sciences (ROIV) United Kingdom $7.784B 0.00
Revolution Medicines (RVMD) United States $7.387B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Repligen (RGEN) United States $6.677B 74.75
Halozyme Therapeutics (HALO) United States $6.507B 12.46
Jazz Pharmaceuticals (JAZZ) Ireland $6.506B 6.39
Legend Biotech (LEGN) United States $6.248B 0.00
Guardant Health (GH) United States $6.088B 0.00
Telix Pharmaceuticals (TLX) Australia $5.801B 0.00
TG Therapeutics (TGTX) United States $5.718B 150.08
Nuvalent (NUVL) United States $5.386B 0.00
Axsome Therapeutics (AXSM) United States $4.958B 0.00
Alkermes (ALKS) Ireland $4.797B 12.87
Akero Therapeutics (AKRO) United States $4.321B 0.00
Vaxcyte (PCVX) United States $4.240B 0.00
ADMA Biologics Inc (ADMA) United States $4.235B 31.68
Zealand Pharma (ZLDPF) Denmark $4.201B 0.00
PTC Therapeutics (PTCT) United States $3.979B 6.92
Rhythm Pharmaceuticals (RYTM) United States $3.944B 0.00
Cytokinetics (CYTK) United States $3.873B 0.00
Krystal Biotech (KRYS) United States $3.828B 29.50
CRISPR Therapeutics AG (CRSP) Switzerland $3.822B 0.00
Zai Lab (ZLAB) China $3.812B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.801B 33.40
Merus (MRUS) Netherlands $3.676B 0.00
SpringWorks Therapeutics (SWTX) United States $3.538B 0.00
Avidity Biosciences (RNA) United States $3.532B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.511B 0.00
Arcellx (ACLX) United States $3.472B 0.00
Protagonist Therapeutics (PTGX) United States $3.306B 71.12
Ascentage Pharma Group - (AAPG) China $3.257B 0.00
Scholar Rock Holding (SRRK) United States $3.232B 0.00
Metsera (MTSR) United States $3.110B 0.00
Kymera Therapeutics (KYMR) United States $2.987B 0.00
Viking Therapeutics (VKTX) United States $2.921B 0.00
Alvotech (ALVO) Luxembourg $2.819B 16.12
MoonLake Immunotherapeutics (MLTX) Switzerland $2.785B 0.00
Immunovant (IMVT) United States $2.701B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.587B 0.00
ImmunityBio (IBRX) United States $2.533B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.494B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.459B 0.00
Anbio Biotechnology (NNNN) Germany $2.317B 0.00
Apellis Pharmaceuticals (APLS) United States $2.223B 0.00
Ligand Pharmaceuticals (LGND) United States $2.201B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.116B 0.00
Vericel (VCEL) United States $2.115B 1400.67
Bavarian Nordic (BVNRY) Denmark $2.111B 11.15
Twist Bioscience (TWST) United States $2.075B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.075B 0.00
Denali Therapeutics (DNLI) United States $2.018B 0.00
Agios Pharmaceuticals (AGIO) United States $1.993B 0.00
Sarepta Therapeutics (SRPT) United States $1.973B 0.00
CG Oncology (CGON) United States $1.948B 0.00
Apogee Therapeutics (APGE) United States $1.932B 0.00
Belite Bio (BLTE) United States $1.926B 0.00
IDEAYA Biosciences (IDYA) United States $1.898B 0.00
NovoCure (NVCR) Jersey $1.861B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.831B 12.17
Disc Medicine (IRON) United States $1.787B 0.00
Amicus Therapeutics (FOLD) United States $1.737B 188.00
Certara (CERT) United States $1.710B 31.94
Tarsus Pharmaceuticals (TARS) United States $1.708B 0.00
Beam Therapeutics (BEAM) United States $1.685B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.647B 0.00
GRAIL (GRAL) United States $1.641B 0.00
Adaptive Biotechnologies (ADPT) United States $1.577B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.574B 0.00
Edgewise Therapeutics (EWTX) United States $1.504B 0.00
Biohaven (BHVN) United States $1.477B 0.00
89BIO (ETNB) United States $1.472B 0.00
ANI Pharmaceuticals (ANIP) United States $1.420B 14.63
Janux Therapeutics (JANX) United States $1.397B 0.00
Celldex Therapeutics (CLDX) United States $1.361B 0.00
Mesoblast (MESO) Australia $1.333B 0.00
Vera Therapeutics (VERA) United States $1.330B 0.00
Travere Therapeutics (TVTX) United States $1.271B 0.00
BGM Group (BGM) China $1.271B 0.00
Structure Therapeutics (GPCR) United States $1.246B 0.00
CureVac (CVAC) Germany $1.220B 5.91
Viridian Therapeutics (VRDN) United States $1.201B 0.00
Dynavax Technologies (DVAX) United States $1.200B 71.36
MannKind (MNKD) United States $1.146B 23.56
Liquidia Technologies (LQDA) United States $1.126B 0.00
Pacira BioSciences (PCRX) United States $1.122B 10.67
Niagen Bioscience (NAGE) United States $1.059B 149.33
Novavax (NVAX) United States $1.038B 2.42
AbCellera Biologics (ABCL) Canada $1.018B 0.00
WAVE Life Sciences (WVE) Singapore $1.013B 0.00
Geron (GERN) United States $0.962B 0.00
Intellia Therapeutics (NTLA) United States $0.953B 0.00
Pharvaris (PHVS) Netherlands $0.941B 0.00
CorMedix Inc (CRMD) United States $0.923B 61.86
Arcus Biosciences (RCUS) United States $0.913B 0.00
Spyre Therapeutics (SYRE) United States $0.905B 0.00
NeoGenomics (NEO) United States $0.901B 0.00
Mineralys Therapeutics (MLYS) United States $0.879B 0.00
Nurix Therapeutics (NRIX) United States $0.876B 0.00
Zymeworks (ZYME) United States $0.868B 0.00
ArriVent BioPharma (AVBP) United States $0.863B 0.00
Praxis Precision Medicines (PRAX) United States $0.862B 0.00
MiMedx (MDXG) United States $0.858B 20.75
LENZ Therapeutics (LENZ) United States $0.843B 0.00
Oculis Holding AG (OCS) Switzerland $0.842B 0.00
Cogent Biosciences (COGT) United States $0.823B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.816B 0.00
Oric Pharmaceuticals (ORIC) United States $0.793B 0.00
UniQure (QURE) Netherlands $0.778B 0.00
Anavex Life Sciences (AVXL) United States $0.776B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Immunome (IMNM) United States $0.761B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Gyre Therapeutics (GYRE) United States $0.757B 201.75
Phathom Pharmaceuticals (PHAT) United States $0.727B 0.00
Vir Biotechnology (VIR) United States $0.723B 0.00
Replimune (REPL) United States $0.715B 0.00
Pharming Group (PHAR) Netherlands $0.711B 0.00
Trevi Therapeutics (TRVI) United States $0.699B 0.00
Immatics (IMTX) Germany $0.682B 0.00
AnaptysBio (ANAB) United States $0.681B 0.00
Urogen Pharma (URGN) United States $0.675B 0.00
Nuvation Bio (NUVB) United States $0.670B 0.00
Iovance Biotherapeutics (IOVA) United States $0.661B 0.00
Arbutus Biopharma (ABUS) United States $0.657B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.641B 0.00
GH Research (GHRS) Ireland $0.640B 0.00
Sionna Therapeutics (SION) United States $0.639B 0.00
Stoke Therapeutics (STOK) United States $0.632B 14.66
Sana Biotechnology (SANA) United States $0.588B 0.00
Upstream Bio (UPB) United States $0.585B 0.00
Sage Therapeutics (SAGE) United States $0.582B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.579B 0.00
Tango Therapeutics (TNGX) United States $0.559B 0.00
Keros Therapeutics (KROS) United States $0.548B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.546B 0.00
Arvinas (ARVN) United States $0.543B 0.00
Dianthus Therapeutics (DNTH) United States $0.542B 0.00
Castle Biosciences (CSTL) United States $0.535B 36.31
Mind Medicine (MindMed) (MNMD) United States $0.533B 0.00
Opthea (OPT) Australia $0.525B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.514B 0.00
MeiraGTx Holdings (MGTX) United States $0.510B 0.00
Bicara Therapeutics (BCAX) United States $0.508B 0.00
Kura Oncology (KURA) United States $0.506B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.502B 0.00
Tyra Biosciences (TYRA) United States $0.490B 0.00
Maze Therapeutics (MAZE) United States $0.490B 0.00
Fortrea Holdings (FTRE) United States $0.481B 13.30
Septerna (SEPN) United States $0.467B 0.00
ATyr Pharma (ATYR) United States $0.465B 0.00
Myriad Genetics (MYGN) United States $0.454B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.453B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.453B 0.00
Cullinan Therapeutics (CGEM) United States $0.453B 0.00
Celcuity (CELC) United States $0.439B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.439B 0.00
Precigen (PGEN) United States $0.428B 0.00
REGENXBIO (RGNX) United States $0.423B 0.00
PureTech Health (PRTC) United States $0.419B 0.00
Kamada (KMDA) Israel $0.414B 24.83
Rapport Therapeutics (RAPP) United States $0.399B 0.00
Erasca (ERAS) United States $0.388B 0.00
Zenas BioPharma (ZBIO) United States $0.384B 0.00
Benitec Biopharma (BNTC) United States $0.384B 0.00
ITeos Therapeutics (ITOS) United States $0.381B 0.00
Abivax SA (ABVX) France $0.379B 0.00
Northwest Biotherapeutics (NWBO) United States $0.378B 0.00
Fulcrum Therapeutics (FULC) United States $0.378B 0.00
Cytek Biosciences (CTKB) United States $0.374B 0.00
Solid Biosciences (SLDB) United States $0.371B 0.00
Tectonic Therapeutic (TECX) United States $0.370B 0.00
Vigil Neuroscience (VIGL) United States $0.370B 0.00
Eton Pharmaceuticals (ETON) United States $0.364B 0.00
Humacyte (HUMA) United States $0.358B 0.00
Absci (ABSI) United States $0.356B 0.00
Rezolute (RZLT) United States $0.351B 0.00
Terns Pharmaceuticals (TERN) United States $0.341B 0.00
Emergent Biosolutions (EBS) United States $0.338B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.333B 0.00
Compass Therapeutics (CMPX) United States $0.332B 0.00
Astria Therapeutics (ATXS) United States $0.331B 0.00
Gossamer Bio (GOSS) United States $0.327B 0.00
MBX Biosciences (MBX) United States $0.326B 0.00
Inventiva S.A (IVA) France $0.315B 0.00
Ocugen (OCGN) United States $0.310B 0.00
Prothena (PRTA) Ireland $0.308B 0.00
Aura Biosciences (AURA) United States $0.304B 0.00
Abeona Therapeutics (ABEO) United States $0.301B 0.00
Alpha Teknova (TKNO) United States $0.297B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.288B 0.00
XOMA Royalty (XOMA) United States $0.288B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.285B 57.88
Olema Pharmaceuticals (OLMA) United States $0.283B 0.00
Atea Pharmaceuticals (AVIR) United States $0.278B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.275B 0.00
Prime Medicine (PRME) United States $0.272B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.271B 0.00
Verastem (VSTM) United States $0.271B 0.00
Entrada Therapeutics (TRDA) United States $0.270B 8.79
Corvus Pharmaceuticals (CRVS) United States $0.270B 0.00
Allogene Therapeutics (ALLO) United States $0.269B 0.00
Sagimet Biosciences (SGMT) United States $0.267B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.266B 0.00
Cidara Therapeutics (CDTX) United States $0.264B 0.00
Foghorn Therapeutics (FHTX) United States $0.263B 0.00
Annexon (ANNX) United States $0.261B 0.00
Amarin (AMRN) Ireland $0.260B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
DBV Technologies S.A (DBVT) France $0.257B 0.00
Lifecore Biomedical (LFCR) United States $0.257B 0.00
Cartesian Therapeutics (RNAC) United States $0.253B 0.00
Neurogene (NGNE) United States $0.253B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
Palvella Therapeutics (PVLA) United States $0.244B 0.00
Aardvark Therapeutics (AARD) United States $0.241B 0.00
Tvardi Therapeutics (TVRD) United States $0.241B 0.00
Candel Therapeutics (CADL) United States $0.238B 0.00
Prima BioMed (IMMP) Australia $0.234B 0.00
BioStem Technologies (BSEM) $0.230B 9.35
Semper Paratus Acquisition (TVGN) United States $0.221B 0.00
MaxCyte (MXCT) United States $0.217B 0.00
Inhibrx Biosciences (INBX) United States $0.216B 0.13
Adherex Technologies (FENC) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Design Therapeutics (DSGN) United States $0.212B 0.00
Cardiff Oncology (CRDF) United States $0.206B 0.00
I-Mab (IMAB) United States $0.204B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.203B 0.00
ScPharmaceuticals (SCPH) United States $0.203B 0.00
Monopar Therapeutics (MNPR) United States $0.201B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.200B 0.00
CARGO Therapeutics (CRGX) United States $0.197B 0.00
GENFIT S.A (GNFT) France $0.196B 0.00
Bright Minds Biosciences (DRUG) United States $0.192B 0.00
Kodiak Sciences (KOD) United States $0.191B 0.00
Codexis (CDXS) United States $0.190B 0.00
AC Immune (ACIU) Switzerland $0.189B 0.00
Citius Oncology (CTOR) United States $0.188B 0.00
CytomX Therapeutics (CTMX) United States $0.187B 4.83
Editas Medicine (EDIT) United States $0.186B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.182B 0.00
Instil Bio (TIL) United States $0.182B 0.00
Nuvectis Pharma (NVCT) United States $0.170B 0.00
Spero Therapeutics (SPRO) United States $0.169B 0.00
Innate Pharma S.A (IPHA) France $0.166B 0.00
Voyager Therapeutics (VYGR) United States $0.164B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.163B 0.00
EnGene Holdings (ENGN) Canada $0.161B 0.00
Ventyx Biosciences (VTYX) United States $0.161B 0.00
Molecular Partners AG (MOLN) Switzerland $0.157B 0.00
Alumis (ALMS) United States $0.156B 0.00
BioAge Labs (BIOA) United States $0.156B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.155B 0.00
DiaMedica Therapeutics (DMAC) United States $0.155B 0.00
Galena Biopharma (SLS) United States $0.154B 0.00
Anika Therapeutics (ANIK) United States $0.152B 0.00
Alector (ALEC) United States $0.147B 0.00
Alpha Cognition (ACOG) Canada $0.147B 0.00
INmune Bio (INMB) United States $0.147B 0.00
Actuate Therapeutics (ACTU) United States $0.147B 0.00
Compugen (CGEN) Israel $0.146B 0.00
Fate Therapeutics (FATE) United States $0.136B 0.00
Kyverna Therapeutics (KYTX) United States $0.133B 0.00
Black Diamond Therapeutics (BDTX) United States $0.132B 38.83
Agenus (AGEN) United States $0.131B 0.00
Elicio Therapeutics (ELTX) United States $0.129B 0.00
BeyondSpring (BYSI) United States $0.128B 0.00
Neumora Therapeutics (NMRA) United States $0.127B 0.00
Nkarta (NKTX) United States $0.126B 0.00
Caribou Biosciences (CRBU) United States $0.125B 0.00
Contineum Therapeutics (CTNM) United States $0.123B 0.00
Rapt Therapeutics (RAPT) United States $0.123B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.120B 0.00
Greenwich LifeSciences (GLSI) United States $0.119B 0.00
Seer (SEER) United States $0.118B 0.00
23andMe Holding (MEHCQ) United States $0.117B 0.00
Theratechnologies (THTX) Canada $0.116B 0.00
BioHarvest Sciences (BHST) Canada $0.116B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.115B 0.00
Genelux (GNLX) United States $0.112B 0.00
TuHURA Biosciences (HURA) United States $0.111B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.109B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.109B 0.00
Sangamo Therapeutics (SGMO) United States $0.107B 0.00
Quantum Biopharma (QNTM) Canada $0.102B 0.00
C4 Therapeutics (CCCC) United States $0.101B 0.00
Whitehawk Therapeutics (WHWK) United States $0.098B 0.00
Forte Biosciences (FBRX) United States $0.097B 0.00
Tenaya Therapeutics (TNYA) United States $0.096B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.094B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Immuneering (IMRX) United States $0.092B 0.00
Coya Therapeutics (COYA) United States $0.092B 0.00
Cabaletta Bio (CABA) United States $0.091B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.090B 0.00
Nautilus Biotechnology (NAUT) United States $0.090B 0.00
Entera Bio (ENTX) Israel $0.090B 0.00
Adagene (ADAG) China $0.090B 0.00
Invivyd (IVVD) United States $0.089B 0.00
Coherus Oncology (CHRS) United States $0.087B 0.00
IO Biotech (IOBT) Denmark $0.086B 0.00
Climb Bio (CLYM) United States $0.082B 0.00
Cellectis S.A (CLLS) France $0.082B 0.00
TScan Therapeutics (TCRX) United States $0.081B 0.00
OKYO Pharma (OKYO) $0.080B 0.00
Pliant Therapeutics (PLRX) United States $0.079B 0.00
Jasper Therapeutics (JSPR) United States $0.077B 0.00
Zura Bio (ZURA) United States $0.077B 0.00
EXoZymes (EXOZ) United States $0.077B 0.00
XBiotech (XBIT) United States $0.076B 0.00
Elutia (ELUT) United States $0.074B 0.00
PDS Biotechnology (PDSB) United States $0.074B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.073B 0.00
Inovio Pharmaceuticals (INO) United States $0.072B 0.00
IGM Biosciences (IGMS) United States $0.070B 0.00
Immunic (IMUX) United States $0.069B 0.00
Biomea Fusion (BMEA) United States $0.068B 0.00
Sutro Biopharma (STRO) United States $0.068B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.067B 0.00
Skye Bioscience (SKYE) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
TELA Bio (TELA) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.065B 0.00
Oncolytics Biotech (ONCY) Canada $0.065B 0.00
Seres Therapeutics (MCRB) United States $0.065B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.063B 0.00
MediciNova (MNOV) United States $0.063B 0.00
Akoya Biosciences (AKYA) United States $0.063B 0.00
Immix Biopharma (IMMX) United States $0.062B 0.00
Alto Neuroscience (ANRO) United States $0.061B 0.00
Repare Therapeutics (RPTX) Canada $0.060B 0.00
CervoMed (CRVO) United States $0.060B 0.00
Quince Therapeutics (QNCX) United States $0.059B 0.00
Renovaro (RENB) United States $0.059B 0.00
VistaGen Therapeutics (VTGN) United States $0.058B 0.00
Connect Biopharma Holdings (CNTB) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
Opus Genetics (IRD) United States $0.057B 0.00
Genenta Science S.p.A (GNTA) Italy $0.056B 0.00
Senti Biosciences (SNTI) United States $0.056B 0.00
Adicet Bio (ACET) United States $0.055B 0.00
Adlai Nortye (ANL) Cayman Islands $0.054B 0.00
ZIVO Bioscience (ZIVO) United States $0.054B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.053B 0.00
InflaRx (IFRX) Germany $0.053B 0.00
Precision BioSciences (DTIL) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.053B 0.00
Fortress Biotech (FBIO) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.051B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
Applied Therapeutics (APLT) United States $0.049B 0.00
PepGen (PEPG) United States $0.047B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
Exicure (XCUR) United States $0.047B 0.00
Adverum Biotechnologies (ADVM) United States $0.047B 0.00
Aligos Therapeutics (ALGS) United States $0.046B 0.00
Shattuck Labs (STTK) United States $0.046B 0.00
Mersana Therapeutics (MRSN) United States $0.046B 0.00
Kalaris Therapeutics (KLRS) United States $0.045B 0.00
Celularity (CELU) United States $0.042B 0.00
Artiva Biotherapeutics (ARTV) United States $0.038B 0.00
Clene (CLNN) United States $0.038B 0.00
Alterity Therapeutics - (ATHE) Australia $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Scilex Holding (SCLX) United States $0.034B 0.00
Rein Therapeutics (RNTX) United States $0.034B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.034B 0.00
Radiopharm Theranostics - (RADX) Australia $0.034B 0.00
Medicus Pharma (MDCX) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.032B 0.00
OnKure Therapeutics (OKUR) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
ABVC BioPharma (ABVC) United States $0.031B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Vor Biopharma (VOR) $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Rani Therapeutics Holdings (RANI) United States $0.029B 0.00
CAMP4 Therapeutics (CAMP) United States $0.028B 0.00
Dyadic (DYAI) United States $0.027B 0.00
FibroBiologics (FBLG) United States $0.027B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.027B 0.00
KALA BIO (KALA) United States $0.026B 0.00
ALX Oncology Holdings (ALXO) United States $0.026B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Passage Bio (PASG) United States $0.024B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Boundless Bio (BOLD) United States $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Curis (CRIS) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Ovid Therapeutics (OVID) United States $0.022B 0.00
Femasys (FEMY) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
BRIACELL THERAP (BCTX) Canada $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Beyond Air (XAIR) United States $0.020B 0.00
Q32 Bio (QTTB) United States $0.019B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.019B 0.00
Aytu BioPharma (AYTU) United States $0.018B 0.00
Longeveron (LGVN) United States $0.018B 0.00
Imunon (IMNN) United States $0.018B 0.00
Cingulate (CING) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Cognition Therapeutics (CGTX) United States $0.016B 0.00
HOOKIPA Pharma (HOOK) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
X4 Pharmaceuticals (XFOR) United States $0.015B 0.00
Gelteq (GELS) Australia $0.015B 0.00
Advanced Biomed (ADVB) Taiwan $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
UNITY Biotechnology (UBX) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
MetaVia (MTVA) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Rallybio (RLYB) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Eyenovia (EYEN) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Equillium (EQ) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Moleculin Biotech (MBRX) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00